>
European Central Bank calls for merchants to participate in digital euro pilot
Iran's Electro-Optical Missiles Take Out F-15s & Warships – Yemen Offensive Shocks Israel
SHOCK CASE REPORT: Advanced Alzheimer's Patient Regains Speech, Memory, Mobility...
HERE WE GO: Evacuations Underway After Massive Wildfire Breaks Out in Los Angeles...
Most artificial limbs rely on silicone or plastic to mimic human hands.
Flying cell tower beams phone signal to Japan from 10 miles up
Chinese Commercial Reactor Achieves Nuclear Fusion with Clean Hydrogen-Boron Fuel
Med Beds Just Took a MASSIVE Step Forward, Healing People in Days!
Palmer Luckey: Autonomous Weapons Are Ancient and Why Anduril Won't Build Humanoids | EP #295
A laser just photographed objects through six feet of concrete
Elon Musk's Next-Gen Motor Destroy Entire EV Industry
China's disputed satellite refueling heralds new space war era
BYD Will Put Solid-State Batteries In An EV Next Year: Executive
FDA-cleared exoskeleton puts spinal-cord patients back on their feet

A stunning medical case is raising new questions about what may still be possible for patients suffering from advanced Alzheimer's disease.
A Japanese-American woman in her 80s who had spent five years barely speaking, unable to walk on her own, and incontinent of urine started talking about her own life again roughly 19 hours after a single oral dose of psilocybin-containing mushrooms, according to a case report published May 28, 2026, in Frontiers in Neuroscience.
The paper, "Transient multidomain functional improvement in advanced Alzheimer's disease following high-dose psilocybin-containing mushroom administration," was written by Marcos Lago, Mariana Cerveira, and Joe Xavier Simonet of the Associação Cruz de Ankh in São Paulo, Brazil. It is one patient. It is not a randomized trial. The authors are explicit that the findings "do not imply disease reversal."
The patient had a clinically diagnosed 10-year history of Alzheimer's disease, including five years of marked hypofunction.
At baseline she spoke mostly in single syllables. She had chronic urinary incontinence, needed help to walk, could not dress herself, had a flat affect, trouble swallowing, and severe loss of spontaneous communication.
She lived under continuous family and caregiver supervision. Formal biomarker confirmation and advanced imaging were not available, and the authors note that a vascular or mixed contribution cannot be fully excluded.
With her son's consent, she was given 5 grams of dried Enigma-strain Psilocybe cubensis by mouth. Importantly, that means 5 grams of mushrooms, not 5 grams of purified psilocybin.
The first stretch was rough. Clinicians suspected hyperthermia. She sweated heavily and dropped into a prolonged deep sleep-like state.
About 19 hours later, near 3:30 a.m., she woke on her own and began an autobiographical conversation that lasted roughly four hours. Her son reported memories and reflections nobody around her had heard her produce in years.
Over the following days the team documented changes across several domains, as reported in the Frontiers paper and summarized by New Scientist and Medical Xpress:
Speech shifted from monosyllables to spontaneous conversation.
Urinary continence returned after more than five years of incontinence, including overnight, with diapers remaining dry.
She walked without assistance by day two.
Within two to three days she was dressing herself and acting on her own initiative.
She held eye contact, smiled back, recognized family, and retrieved contextual details, asking where a person had gone, recognizing a rented car.